Altimmune Announces Corporate Headquarters Relocation to New Jersey

On June 16, 2026, Altimmune, Inc. announced plans to relocate its corporate headquarters from Gaithersburg, Maryland, to Morristown, New Jersey, later in the year. The company cited the strategic advantage of moving to a geography with a high concentration of biopharmaceutical companies to better attract top-tier talent as it transitions into a late-stage development company. In connection with the move, Altimmune has entered into a five-year office lease agreement for the new New Jersey location. The lease involves annual rent payments of approximately $300,000. Management expects the relocation to improve long-term cost efficiencies and support the company's hybrid business model. The filing also included standard cautionary language regarding forward-looking statements, noting that the move's timing and anticipated benefits, such as talent acquisition and cost savings, are subject to various risks and uncertainties.